2025.12.12
Serum-containing cell freezing media, a longstanding choice in life science research, faces critical limitations: its undefined, variable composition undermines experimental reproducibility, animal-derived serum poses biosafety risks (pathogens, xenogeneic proteins) and ethical concerns, and it encounters regulatory hurdles for clinical translation.
Against this backdrop, our Cell Freezing Media-Serum Free is officially launched—a cutting-edge solution redefining cell preservation. Manufactured under GMP-like systems, it is serum-free, xeno-free, and protein-free, eliminating contamination risks and ethical issues while aligning with regulatory demands. Its strict batch testing ensures minimal variation, guaranteeing stable, reproducible results for long-term research, large-scale cell banking, and clinical studies.
Boasting an optimized proprietary formula, it maintains ≥90% post-thaw cell viability and preserves functionality (proliferation, differentiation) better than serum-based media, with broad compatibility for mammalian primary cells, stem cells, immune cells, tumor lines, and organoids. As a ready-to-use product, it eliminates tedious serum preparation, boosting research efficiency, and each batch comes with a detailed Certificate of Analysis (CoA) for quality assurance.
This launch reflects our commitment to delivering innovative, standardized solutions for the life sciences community. Empower your research progress, experimental reliability, and clinical translation with our serum-free media.
For inquiries, free samples, or technical docs, contact Info@milecell-bio.com.
Join us for a safer, more consistent future of cell cryopreservation!
